|
|||||
|
|
Theoretical basis for interest in acetylprocainamide and clinical experiences with this new antiarrhythmic agent. |
|
| Authors: | D Drayer J Kluger M Reidenberg R Lahita |
| Abstract: | In conclusion, it was the differential responses of slow and rapid acetylators to procainamide therapy that gave the initial clues that acetylprocainamide might be a safer drug than procainamide. So far, the experience with acetylprocainamide has been encouraging. |
| Keywords: | |